carmen li
Jul 15, 2013
Ethical grounding likely to help minimise GSK fallout in China
BEIJING – PR industry observers suggest that recent confessions by GlaxoSmithKline (GSK) executives to involvement in bribery and tax offences in China are unlikely to prove a long-term setback for the company.
Top news, insights and analysis every weekday
Sign up for Campaign Bulletins